These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7935175)

  • 1. Effects of CPT-11 (a unique DNA topoisomerase I inhibitor) on a highly malignant xeno-transplanted neuroblastoma.
    Komuro H; Li P; Tsuchida Y; Yokomori K; Nakajima K; Aoyama T; Kaneko M; Kaneda N
    Med Pediatr Oncol; 1994; 23(6):487-92. PubMed ID: 7935175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice.
    Choi SH; Tsuchida Y; Yang HW
    Cancer Lett; 1998 Feb; 124(1):15-21. PubMed ID: 9500186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
    Vassal G; Terrier-Lacombe MJ; Bissery MC; Vénuat AM; Gyergyay F; Bénard J; Morizet J; Boland I; Ardouin P; Bressac-de-Paillerets B; Gouyette A
    Br J Cancer; 1996 Aug; 74(4):537-45. PubMed ID: 8761367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor expression is closely related to irinotecan-mediated inhibition of tumor growth and angiogenesis in neuroblastoma xenografts.
    Kaneko S; Ishibashi M; Kaneko M
    Cancer Sci; 2008 Jun; 99(6):1209-17. PubMed ID: 18384433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of newly introduced chemotherapeutic agents on a cytogenetically highly malignant neuroblastoma, xenotransplanted in nude mice.
    Makino S; Kashii A; Kanazawa K; Tsuchida Y
    J Pediatr Surg; 1993 Apr; 28(4):612-6. PubMed ID: 8483078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor activity of CPT-11 in experimental human ovarian cancer and human soft-tissue sarcoma.
    Jansen WJ; Kolfschoten GM; Erkelens CA; Van Ark-Otte J; Pinedo HM; Boven E
    Int J Cancer; 1997 Dec; 73(6):891-6. PubMed ID: 9399672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent therapeutic activity of irinotecan (CPT-11) and its schedule dependency in medulloblastoma xenografts in nude mice.
    Vassal G; Boland I; Santos A; Bissery MC; Terrier-Lacombe MJ; Morizet J; Sainte-Rose C; Lellouch-Tubiana A; Kalifa C; Gouyette A
    Int J Cancer; 1997 Sep; 73(1):156-63. PubMed ID: 9334824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of CPT-11, a camptothecin derivative, on human testicular tumor xenografts in nude mice.
    Miki T; Sawada M; Nonomura N; Kojima Y; Okuyama A; Maeda O; Saiki S; Kotake T
    Eur Urol; 1997; 31(1):92-6. PubMed ID: 9032542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan.
    Calvet L; Santos A; Valent A; Terrier-Lacombe MJ; Opolon P; Merlin JL; Aubert G; Morizet J; Schellens JH; Bénard J; Vassal G
    Br J Cancer; 2004 Sep; 91(6):1205-12. PubMed ID: 15292932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.
    Thompson J; Zamboni WC; Cheshire PJ; Lutz L; Luo X; Li Y; Houghton JA; Stewart CF; Houghton PJ
    Clin Cancer Res; 1997 Mar; 3(3):423-31. PubMed ID: 9815701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
    Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
    Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts.
    Kaneko M; Kaneko S; Suzuki K
    Cancer Sci; 2009 Nov; 100(11):2193-201. PubMed ID: 19673886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-topoisomerase I, a new target for the treatment of neuroblastoma.
    Vassal G; Pondarré C; Cappelli C; Terrier-Lacombe MJ; Boland I; Morizet J; Bénard J; Vénuat AM; Ardouin P; Hartmann O; Gouyette A
    Eur J Cancer; 1997 Oct; 33(12):2011-5. PubMed ID: 9516844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterations.
    Santos A; Calvet L; Terrier-Lacombe MJ; Larsen A; Bénard J; Pondarré C; Aubert G; Morizet J; Lavelle F; Vassal G
    Cancer Res; 2004 May; 64(9):3223-9. PubMed ID: 15126363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials using irinotecan.
    Houghton PJ; Santana VM
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):84-5. PubMed ID: 11990709
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts.
    Hare CB; Elion GB; Houghton PJ; Houghton JA; Keir S; Marcelli SL; Bigner DD; Friedman HS
    Cancer Chemother Pharmacol; 1997; 39(3):187-91. PubMed ID: 8996518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan.
    Gomez-Manzano C; Alonso MM; Yung WK; McCormick F; Curiel DT; Lang FF; Jiang H; Bekele BN; Zhou X; Alemany R; Fueyo J
    Clin Cancer Res; 2006 Jan; 12(2):556-62. PubMed ID: 16428500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclophosphamide, cis-platinum, nitrosourea (ACNU), melphalan, and dacarbazine on a cytogenetically highly malignant neuroblastoma xenograft.
    Makino S; Tsuchida Y; Nakajo T; Kanda N; Kaneko Y
    Med Pediatr Oncol; 1986; 14(1):36-40. PubMed ID: 2419742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.
    Kumazawa E; Jimbo T; Ochi Y; Tohgo A
    Cancer Chemother Pharmacol; 1998; 42(3):210-20. PubMed ID: 9685056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor.
    Pastorino F; Loi M; Sapra P; Becherini P; Cilli M; Emionite L; Ribatti D; Greenberger LM; Horak ID; Ponzoni M
    Clin Cancer Res; 2010 Oct; 16(19):4809-21. PubMed ID: 20702613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.